Advertisement

Topics

Replicon Corporate Finance Oy/Ltd Company Profile

11:45 EDT 18th June 2018 | BioPortfolio

Replicon is privately held, independent investment banking service company located in Helsinki, Finland. We provide first-class corporate finance and strategic advisory to our clients. Our range of expertise covers e.g. private equity transactions, M&A advisory, project financing and valuation services. We also provide financial and strategic consulting when related to financial arrangements or re-structuring.

Location

Aleksanterinkatu 17, 4th floorP.O. Box 800
Helsinki
FIN-00101
Finland

Contact

Phone: 358 (0)9 677 464
Fax: 358 9 677 464
Email: info@replicon.fi


News Articles [447 Associated News Articles listed on BioPortfolio]

Virbac : Availability of annual report 2017

Virbac: Availability of annual report 2017 Public release - April 26, 2018 The annual report of the fiscal year ending at December 31, 2017 of Virbac is available: · on our ...

Scott+Scott Attorneys at Law LLP Announces Investigation into Longfin Corp. (LFIN)

Longfin is an independent finance and technology company that specializes in structured trade finance solutions and physical commodities finance solutions for finance houses and trading Read more....

Virbac: Availability of the quarterly financial information as of March 31, 2018

Virbac: Availability of the quarterly financial information as of March 31, 2018 Public release - May 15, 2018 The quarterly financial information as of March 31, 2018 is available: · ...

Researchers Perform Targeted Mutation and Gene Replacement in Tomato

Targeted genome editing is becoming an increasingly important tool for precise plant breeding. A team led by Tal Dahan‐Meir from Weizmann Institute of Science in Israel used a combination of the CRI...

Bridging Finance Announces Recent Deals

TORONTO, Feb. 16, 2018/PRNewswire/ - Bridging Finance Inc. ("Bridging Finance")announces a sample of deals made since the 3 Rea...

#jobs #lifescience Controller/Director of Finance

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Controller/Director of Finance .NY-Manhattan, Controller/Director of Finance ...

#jobs #lifescience Marketplace Technical: Finance Administrator

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Marketplace Technical: Finance Administrator . Up to £25,000: Marketplace Te...

ASTAD Wins two International Finance Awards

Qatar'sASTAD has won the International Finance award for Best Construction Project Management Team, Qatar2017 and its CEO Engineer Ali Al-Khalifahas won the Read more...

PubMed Articles [51 Associated PubMed Articles listed on BioPortfolio]

Eight Characteristics of an Efficient Finance Department.

Assessing the finance department’s strengths and weaknesses can help achieve solvency.

Development of a replicon cell line-based high throughput antiviral assay for screening inhibitors of Zika virus.

Zika virus (ZIKV) is an important emerging human pathogen associated with microcephaly, Guillain-Barré syndrome and meningoencephalitis. Developing rapid and reliable HTS assay is important for ZIKV ...

Development of robust genotype 1a hepatitis C replicons harboring adaptive mutations for facilitating the antiviral drug discovery and study of virus replication.

The hepatitis C virus (HCV) subgenomic replicon is a valuable tool for studying virus replication and HCV drug development. Despite the fact that HCV genotype 1a (HCV1a) is the most prevalent genotype...

Carbon Emission Reduction with Capital Constraint under Greening Financing and Cost Sharing Contract.

Motivated by the industrial practices, this work explores the carbon emission reductions for the manufacturer, while taking into account the capital constraint and the cap-and-trade regulation. To all...

Does finance affect environmental degradation: evidence from One Belt and One Road Initiative region?

This paper explores the effects of finance on environmental degradation and investigates environmental Kuznets curve (EKC) of each country among 52 that participate in the One Belt and One Road Initia...

Clinical Trials [11 Associated Clinical Trials listed on BioPortfolio]

A Clinical Trial of an Alphavirus Replicon Vaccine for Cytomegalovirus (CMV)

AVX601, a bivalent alphavirus replicon vaccine expressing three CMV proteins (gB, pp65 and IE1) is a candidate vaccine against cytomegalovirus (CMV). The objectives of this Phase 1 study ...

A Phase 1/2 Clinical Trial of an Alphavirus Replicon Vaccine for Influenza

AVX502, an alphavirus replicon vaccine expressing an influenza HA protein, is a candidate vaccine against influenza. The objectives of this Phase 1 study are to test the safety of the vac...

Effect of a Micro-finance-based Intervention for the Prevention of Intimate-partner Violence and HIV

The high rates of HIV infection in women have brought into sharp focus the problem of violence against women. There is a growing recognition that women and girls' risk of and vulnerability...

Safety of and Immune Response to an HIV-1 Subtype C Vaccine (AVX101) in HIV Uninfected Adults

The purpose of this study is to evaluate the safety of and immune response to an alphavirus replicon, HIV-1 subtype C gag vaccine, AVX101, in HIV uninfected adults in the United States, So...

The Influence of Significant Weight Lost on the Quality of Voice

The rate of obesity and bariatric surgery is rising steadily. Though Bariatric Surgery Influences on aspects such as endocrin analysis, finance, etc are well tested, quantitative and quali...

Companies [447 Associated Companies listed on BioPortfolio]

Replicon Corporate Finance Oy/Ltd

Replicon is privately held, independent investment banking service company located in Helsinki, Finland. We provide first-class corporate finance and strategic advisory to our clients. Our range of ex...

B. Riley & Co., LLC

B. Riley & Co. is a leading independent investment bank which provides a full array of corporate finance, research, sales, trading and otcqx dad services to corporate, institution...

Corporate Action Network

Corporate Action Network was founded to address the imbalance of power between corporations and people. Using the new tools of the Action Network and a networked approach, Corpora...

International Business Forum

IBF – International Business Forum presents financial and business conferences on venture capital, corporate finance, mergers & acquisitions, corporate strategic investing, defined contribution/401(...

Replicon Technologies Incorporated

Replicon Technologies, Inc. (RTI) is an emerging biotechnology company focused on the use of replicons, non-replicating RNA viral particles, for the treatment of patients with cancer. RTI is founded ...

More Information about "Replicon Corporate Finance Oy/Ltd" on BioPortfolio

We have published hundreds of Replicon Corporate Finance Oy/Ltd news stories on BioPortfolio along with dozens of Replicon Corporate Finance Oy/Ltd Clinical Trials and PubMed Articles about Replicon Corporate Finance Oy/Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Replicon Corporate Finance Oy/Ltd Companies in our database. You can also find out about relevant Replicon Corporate Finance Oy/Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record